Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 7:10 AM UTC
| NCT Number | NCT06225804 |
| Recruiting Status | Recruiting |
| Condition | Non-Small Cell Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 164 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Abbisko Therapeutics Co, Ltd |
| Last Updated on CT.gov | March 18, 2024 (Mar 18, 2024) |
As of July 17, 2026: Clinical trial NCT06225804 is currently recruiting participants. This phase1 study for non-small cell lung cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Abbisko Therapeutics Co, Ltd. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06225804 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06225804 was last updated Mar 18, 2024 (March 18, 2024). HelloStudys verifies this status automatically.